Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
61
datasets available to search
ShareScore release 0.9.0
Dataset results
61 results for “Lutetium”
Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer
ClinicalTrials.gov study NCT06139575. IPD Sharing: YES. Countries: 1. Publications: 0.
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
ClinicalTrials.gov study NCT05803941. IPD Sharing: YES. Countries: 11. Publications: 0.
A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT07047118. IPD Sharing: YES. Countries: 15. Publications: 0.
Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors
ClinicalTrials.gov study NCT04234568. IPD Sharing: YES. Countries: 1. Publications: 0.
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC
ClinicalTrials.gov study NCT06894511. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
ClinicalTrials.gov study NCT07226986. IPD Sharing: YES. Countries: 1. Publications: 0.
Retrospective Analysis of Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®)
ClinicalTrials.gov study NCT05816720. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT07093801. IPD Sharing: NO. Countries: 1. Publications: 0.
A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer
ClinicalTrials.gov study NCT06516510. IPD Sharing: NO. Countries: 3. Publications: 0.
Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors
ClinicalTrials.gov study NCT05247905. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT06517719. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
ClinicalTrials.gov study NCT07200830. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Quantification With Lutetium-177 on Cadmium-Zinc-Telluride Camera 3D
ClinicalTrials.gov study NCT06783088. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer
ClinicalTrials.gov study NCT00005067. IPD Sharing: Not stated. Countries: 1. Publications: 0.
LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate Cancer Patients Treated With PSMA Radioligand THerapy.
ClinicalTrials.gov study NCT07370597. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
ClinicalTrials.gov study NCT07274852. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial
ClinicalTrials.gov study NCT06066437. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT06553846. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE
ClinicalTrials.gov study NCT04919226. IPD Sharing: Not stated. Countries: 10. Publications: 0.
Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)
ClinicalTrials.gov study NCT07290270. IPD Sharing: NO. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.